Senior insider sale
Chief Financial Officer at SKYE BIOSCIENCE, INC. — senior position signals high conviction
$314.5K
57.08K shares
What this filing means
ARSENAULT KAITLYN plans to sell 57.08K shares of SKYE BIOSCIENCE, INC. valued at approximately $314.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/15/2024ACC: 0001967940-24-000093
Officer· Chief Financial Officer
Since Oct 2021
57.08K
Shares to sell
$314.5K
Approx. market value
57.08K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Compensation
NA
11/15/2024
57.08KTotal acquired57.08K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/15/2024 | Compensation NA | 57.08K | — |
| Total | 57.08K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
57.08K
Market value
$314.5K
11/15/2024
Total
Units
57.08K
Value
$314.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/15/2024 | 57.08K | $314.5K | Nasdaq | Planned |
| Total | 57.08K | $314.5K | ||